speb/financial-data huggingface dataset:
Financial ratios for LAVV3.SA — quarterly report dated 2025-06-30
Total revenue: 87936861.31386861
Gross profit: 30028649.635036495
Operating income: 20632846.715328466
Net income: 23456751.824817516
Capital expenditures: 22627.73722627737
Operating cash flow: 4532481.751824818
Depreciation & amortization: 17153.284671532845
Net tangible assets: 284790328.46715325
Owner earnings: 23451277.372262772
Return on net tangible assets (%): 8.234576468409657
Capex to operating income (%): 0.10966851805992853
Buffett classification: The Great
Stock price: 1.9397810218978102
P/E ratio: 9.4338934691563
Shares outstanding: 195434352
Book value: 331332481.75182474
P/B ratio: 1.1441674689789405
Market cap (USD): 379099847.03649634
Debt to equity: 0.2245831089022318
Current ratio: 3.8414718140478277
Quick ratio: 2.5241808868630065
Effective tax rate (%): 11.011498868112621
Interest coverage ratio: 4.97198891869311
COGS to revenue (%): 65.85203384976779
SG&A to revenue (%): 10.314924028935822
Free cash flow (dilution-adjusted): 4509854.01459854
Buyback yield (%): 0
Retained earnings: 37495437.95620438
Inventory turnover: 0.3266165014218975
Receivables turnover: 0.4728525857086646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6586719371630507
FCF margin (%): 5.128513739536081
Revenue growth (%): 51.36608229025587
Rule of 40 score: 56.49459602979195
Financial ratios for LAVV3.SA — quarterly report dated 2025-09-30
Total revenue: 77961090.2255639
Gross profit: 27548120.30075188
Operating income: 16703195.488721803
Net income: 21804323.308270674
Capital expenditures: 1816729.3233082707
Operating cash flow: -1143045.112781955
Depreciation & amortization: 1531766.917293233
Net tangible assets: 289419736.84210527
Owner earnings: 21519360.902255636
Return on net tangible assets (%): 7.435346717212882
Capex to operating income (%): 10.876537513644907
Buffett classification: The Great
Stock price: 2.4210526315789473
P/E ratio: 7.632891716535761
Shares outstanding: 195434352
Book value: 340430827.06766915
P/B ratio: 1.3898766345166342
Market cap (USD): 473156852.2105263
Debt to equity: 0.2494379081791538
Current ratio: 3.524534939117045
Quick ratio: 2.2115753252998993
Effective tax rate (%): 11.97192183646367
Interest coverage ratio: 5.59860131048387
COGS to revenue (%): 64.66427005952941
SG&A to revenue (%): 10.8237915096455
Free cash flow (dilution-adjusted): -2959774.4360902254
Buyback yield (%): 0
Retained earnings: 58164285.71428571
Inventory turnover: 0.23060453974447495
Receivables turnover: 0.38121556101932486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8390739853843323
FCF margin (%): -3.796476457072041
Revenue growth (%): -11.34424283429755
Rule of 40 score: -15.14071929136959
Financial ratios for LAVV3.SA — quarterly report dated 2025-12-31
Total revenue: 96737408.75912409
Gross profit: 32597262.773722626
Operating income: 18908394.16058394
Net income: 22493978.10218978
Capital expenditures: 1332664.2335766421
Operating cash flow: -23819160.583941605
Depreciation & amortization: 427554.74452554743
Net tangible assets: 272667153.2846715
Owner earnings: 21588868.613138687
Return on net tangible assets (%): 7.917663845120118
Capex to operating income (%): 7.048003242679843
Buffett classification: The Great
Stock price: 2.703770197486535
P/E ratio: 6.254612900938936
Shares outstanding: 195434352
Book value: 324962773.72262776
P/B ratio: 1.6260618730246235
Market cap (USD): 528409576.502693
Debt to equity: 0.27111303035271866
Current ratio: 4.463437778937867
Quick ratio: 2.704402539343932
Effective tax rate (%): 11.75548364927553
Interest coverage ratio: 4.868351813568878
COGS to revenue (%): 66.30335338535919
SG&A to revenue (%): 10.85073030496811
Free cash flow (dilution-adjusted): -25151824.817518245
Buyback yield (%): 0
Inventory turnover: 0.25015194669695634
Receivables turnover: 0.4478935642246831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8097640235339227
FCF margin (%): -26.000101863536813
Revenue growth (%): 24.084217497773423
Rule of 40 score: -1.9158843657633895
Financial ratios for LAVV3.SA — annual report dated 2025-12-31
Total revenue: 321422992.7007299
Gross profit: 112282664.23357664
Operating income: 69282481.75182481
Net income: 84701459.85401459
Capital expenditures: 3333211.6788321165
Operating cash flow: -39661678.83211678
Depreciation & amortization: 1982299.2700729927
Net tangible assets: 272667153.2846715
Owner earnings: 83350547.44525547
Return on net tangible assets (%): 30.568605877597356
Capex to operating income (%): 4.8110454396999485
Buffett classification: The Great
Stock price: 2.703770197486535
P/E ratio: 6.238494323632936
Shares outstanding: 195434352
Book value: 324962773.72262776
P/B ratio: 1.6260618730246235
Market cap (USD): 528409576.502693
Debt to equity: 0.27111303035271866
Current ratio: 4.463437778937867
Quick ratio: 2.704402539343932
Effective tax rate (%): 10.512424545635069
Interest coverage ratio: 6.025997936671693
COGS to revenue (%): 65.06700927331586
SG&A to revenue (%): 10.023799277619254
Free cash flow (dilution-adjusted): -42994890.510948904
Buyback yield (%): 0
Inventory turnover: 0.815664814838538
Receivables turnover: 1.4881863352672848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.29529123595396
FCF margin (%): -13.376420320677099
Revenue growth (%): 28.21244284612013
Rule of 40 score: 14.836022525443031
Financial ratios for LBI.V — annual report dated 2022-05-31
Total revenue: 2769765.3543307087
Operating income: 713948.8188976378
Net income: -77036.22047244094
Capital expenditures: 0
Operating cash flow: 31510.23622047244
Net tangible assets: 9182741.732283464
Owner earnings: -77036.22047244094
Return on net tangible assets (%): -0.838923958860862
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.11811023622047244
Shares outstanding: 39271171
Book value: 9182741.732283466
P/B ratio: 0.5051135509079767
Market cap (USD): 4638327.283464567
Debt to equity: 0.04536274054667082
Current ratio: 13.735109651060645
Quick ratio: 13.735109651060645
Interest coverage ratio: 7.676869020404707
COGS to revenue (%): 0
SG&A to revenue (%): 25.85855363966702
Free cash flow (dilution-adjusted): -44983.46456692913
Buyback yield (%): 0
Retained earnings: 2070898.4251968504
Receivables turnover: 159.77480014534885
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.1226171206124205
FCF margin (%): -1.6240893654256505
Rule of 40 score: -1.6240893654256505
Financial ratios for LBI.V — annual report dated 2023-05-31
Total revenue: 562652.9411764706
Operating income: -3688819.8529411764
Net income: -3641009.558823529
Capital expenditures: 0
Operating cash flow: -75197.05882352941
Net tangible assets: 4938613.235294118
Owner earnings: -3641009.558823529
Return on net tangible assets (%): -73.72534323608943
Buffett classification: The Gruesome
Stock price: 0.09558823529411764
Shares outstanding: 39271171
Book value: 4936362.5
P/B ratio: 0.7604510272135665
Market cap (USD): 3753861.933823529
Debt to equity: 0.07036513102869715
Current ratio: 6.07139033565406
Quick ratio: 6.07139033565406
Interest coverage ratio: -114.62244105282399
COGS to revenue (%): 0
SG&A to revenue (%): 118.79188403675862
Free cash flow (dilution-adjusted): -75197.05882352941
Buyback yield (%): 0
Retained earnings: -1707155.882352941
Receivables turnover: 65.58738321762236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -72.67467043000768
FCF margin (%): -13.364732203531588
Revenue growth (%): -79.6858986521466
Rule of 40 score: -93.0506308556782
Financial ratios for LBI.V — annual report dated 2024-05-31
Total revenue: 165852.55474452552
Operating income: -2131942.335766423
Net income: -2274981.02189781
Capital expenditures: 0
Operating cash flow: 434027.00729927
Net tangible assets: 2615764.9635036495
Owner earnings: -2274981.02189781
Return on net tangible assets (%): -86.97192039955375
Buffett classification: The Gruesome
Stock price: 0.072992700729927
Shares outstanding: 39271171
Book value: 2616396.3503649635
P/B ratio: 1.0955942633526974
Market cap (USD): 2866508.8321167883
Debt to equity: 0.08051080454729201
Current ratio: 1.4529464033158508
Quick ratio: 1.4529464033158508
Interest coverage ratio: -133.21600912200682
COGS to revenue (%): 0
SG&A to revenue (%): 346.47475112006975
Free cash flow (dilution-adjusted): 434027.00729927
Buyback yield (%): 0
Retained earnings: -3972541.605839416
Receivables turnover: 2.729706027222816
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -81.4839210224795
FCF margin (%): 261.6944960346451
Revenue growth (%): -70.5231160086467
Rule of 40 score: 191.17138002599842
Financial ratios for LBI.V — quarterly report dated 2024-11-30
Total revenue: 44802.857142857145
Operating income: 602813.5714285715
Net income: 705125.7142857143
Capital expenditures: 572.8571428571429
Operating cash flow: -94637.14285714287
Net tangible assets: 3115423.571428572
Owner earnings: 704552.8571428572
Return on net tangible assets (%): 22.614994108803824
Capex to operating income (%): 0.09503056500529065
Buffett classification: The Great
Stock price: 0.09285714285714286
P/E ratio: 1.292893118856212
Shares outstanding: 39271171
Book value: 3112462.1428571427
P/B ratio: 1.171615450514946
Market cap (USD): 3646608.7357142856
Debt to equity: 0.18056329772915197
Current ratio: 1.7599479606809858
Quick ratio: 1.7599479606809858
Interest coverage ratio: 62.42614098675937
COGS to revenue (%): 0
SG&A to revenue (%): 248.26063388814487
Free cash flow (dilution-adjusted): -95210
Buyback yield (%): 0
Retained earnings: -3326068.571428572
Receivables turnover: 0.5729317951387937
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.367739871534873
FCF margin (%): -212.5087685734328
Rule of 40 score: -212.5087685734328
Financial ratios for LBI.V — quarterly report dated 2025-02-28
Total revenue: -73913.19444444445
Operating income: -550208.3333333334
Net income: -520547.9166666667
Capital expenditures: 42447.91666666667
Operating cash flow: 167854.86111111112
Net tangible assets: 2517827.777777778
Owner earnings: -562995.8333333334
Return on net tangible assets (%): -22.36037898629551
Buffett classification: The Gruesome
Stock price: 0.06944444444444445
Shares outstanding: 39271171
Book value: 2514956.9444444445
P/B ratio: 1.0843782669131181
Market cap (USD): 2727164.652777778
Debt to equity: 0.21866952659339764
Current ratio: 1.2477303589632756
Quick ratio: 1.2477303589632756
Interest coverage ratio: -52.221196941734775
Free cash flow (dilution-adjusted): 125406.94444444445
Buyback yield (%): 0
Retained earnings: -3754234.027777778
Receivables turnover: -0.9629425229121242
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.877445438926777
Revenue growth (%): -264.97428770840867
Rule of 40 score: -264.97428770840867
Financial ratios for LBI.V — annual report dated 2025-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09420289855072465
Shares outstanding: 39271171
Market cap (USD): 3699458.13768116
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LBI.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: 87228.46715328467
Net income: -52497.8102189781
Capital expenditures: 0
Operating cash flow: -216522.62773722626
Net tangible assets: 1196066.4233576641
Owner earnings: -52497.8102189781
Return on net tangible assets (%): -4.389205247615205
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.072992700729927
Shares outstanding: 39271171
Book value: 1108005.1094890512
P/B ratio: 2.5870899037989625
Market cap (USD): 2866508.8321167883
Debt to equity: 0.7341839447102604
Current ratio: 1.1571124837623603
Quick ratio: 1.1571124837623603
Interest coverage ratio: 0.9353929725964136
Free cash flow (dilution-adjusted): -216522.62773722626
Buyback yield (%): 0
Retained earnings: -6204888.3211678825
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.872569034768212
Rule of 40 score: 0
Financial ratios for LBI.V — quarterly report dated 2025-11-30
Total revenue: -89998.57142857143
Operating income: 951576.4285714286
Net income: 1237435
Capital expenditures: 0
Operating cash flow: -349661.4285714286
Net tangible assets: 2382680
Owner earnings: 1237435
Return on net tangible assets (%): 51.93458626420669
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.24285714285714288
P/E ratio: 6.963986866489259
Shares outstanding: 39271171
Book value: 2294470
P/B ratio: 4.1566393919791
Market cap (USD): 9537284.385714287
Debt to equity: 0.3494974563064362
Current ratio: 1.93059975326789
Quick ratio: 1.93059975326789
Interest coverage ratio: 11.300328269333537
Free cash flow (dilution-adjusted): -349661.4285714286
Buyback yield (%): 0.04570782979707939
Retained earnings: -4834491.428571429
Receivables turnover: -2.49387407715298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 41.47260276104846
Rule of 40 score: 0
Financial ratios for LBRDA — annual report dated 2021-12-31
Capital expenditures: 134000000
Depreciation & amortization: 267000000
Buffett classification: The Gruesome
Stock price: 150.8
Shares outstanding: 18254690
Market cap (USD): 2752807252
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LBRDA — annual report dated 2022-12-31
Total revenue: 975000000
Operating income: 28000000
Net income: 1257000000
Capital expenditures: 181000000
Operating cash flow: -56000000
Depreciation & amortization: 262000000
Net tangible assets: 6625000000
Owner earnings: 1338000000
Return on net tangible assets (%): 20.19622641509434
Capex to operating income (%): 646.4285714285714
Buffett classification: The Gruesome
Stock price: 71.09
P/E ratio: 1.0323992936356405
Shares outstanding: 18254690
Book value: 8501000000
P/B ratio: 0.1526556772262087
Market cap (USD): 1297725912.1000001
Debt to equity: 0.45724032466768616
Current ratio: 0.3940298507462687
Quick ratio: 0.3940298507462687
Effective tax rate (%): 18.05736636245111
Interest coverage ratio: 0.21052631578947367
COGS to revenue (%): 0
SG&A to revenue (%): 44.30769230769231
Free cash flow (dilution-adjusted): -274000000
Buyback yield (%): 222.08079326522062
Retained earnings: 5155000000
Receivables turnover: 4.850746268656716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.20791564565233533
FCF margin (%): -28.102564102564102
Rule of 40 score: -28.102564102564102
Financial ratios for LBRDA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -39000000
Net income: 688000000
Capital expenditures: 222000000
Operating cash flow: -261000000
Depreciation & amortization: 230000000
Net tangible assets: 7197000000
Owner earnings: 696000000
Return on net tangible assets (%): 9.670696123384744
Buffett classification: The Gruesome
Stock price: 75.58
P/E ratio: 2.005362602034884
Shares outstanding: 18254690
Book value: 9023000000
P/B ratio: 0.15290806496730577
Market cap (USD): 1379689470.2
Debt to equity: 0.4232516901252355
Current ratio: 2.4157303370786516
Quick ratio: 2.4157303370786516
Effective tax rate (%): 21.263669501822598
Interest coverage ratio: -0.25161290322580643
Free cash flow (dilution-adjusted): -276000000
Buyback yield (%): 16.452977637576232
Retained earnings: 5843000000
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.25221496475457544
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for LBRDA — quarterly report dated 2024-09-30
Capital expenditures: 60000000
Depreciation & amortization: 55000000
Buffett classification: The Gruesome
Stock price: 72
Shares outstanding: 18254690
Market cap (USD): 1314337680
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LBRDA — quarterly report dated 2024-12-31
Capital expenditures: 64000000
Depreciation & amortization: 50000000
Buffett classification: The Gruesome
Stock price: 69.69
Shares outstanding: 18254690
Market cap (USD): 1272169346.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LBRDA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -50000000
Net income: 869000000
Capital expenditures: 247000000
Operating cash flow: -174000000
Depreciation & amortization: 207000000
Net tangible assets: 9793000000
Owner earnings: 829000000
Return on net tangible assets (%): 8.465230266516901
Buffett classification: The Gruesome
Stock price: 69.69
P/E ratio: 1.463946313118527
Shares outstanding: 18254690
Book value: 9808000000
P/B ratio: 0.1297073150591354
Market cap (USD): 1272169346.1
Debt to equity: 0.27396003262642743
Current ratio: 2.115
Quick ratio: 2.115
Effective tax rate (%): 19.023397761953202
Interest coverage ratio: -0.3448275862068966
Free cash flow (dilution-adjusted): -189000000
Buyback yield (%): 6.995923952486439
Retained earnings: 6712000000
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3032692424334324
Rule of 40 score: 0
Financial ratios for LBRDA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -13000000
Net income: 268000000
Capital expenditures: 65000000
Operating cash flow: -41000000
Depreciation & amortization: 53000000
Net tangible assets: 8305000000
Owner earnings: 256000000
Return on net tangible assets (%): 3.082480433473811
Buffett classification: The Gruesome
Stock price: 79.66
P/E ratio: 1.3565005647388058
Shares outstanding: 18254690
Book value: 10067000000
P/B ratio: 0.14444905189232143
Market cap (USD): 1454168605.3999999
Debt to equity: 0.38581503923711136
Current ratio: 1.3909249563699826
Quick ratio: 1.3909249563699826
Effective tax rate (%): -7.834101382488479
Interest coverage ratio: -0.43333333333333335
Free cash flow (dilution-adjusted): -42000000
Buyback yield (%): 0
Retained earnings: 6980000000
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.07916209962245768
Rule of 40 score: 0
Financial ratios for LBRDA — quarterly report dated 2025-06-30
Total revenue: 261000000
Operating income: 41000000
Net income: 383000000
Capital expenditures: 54000000
Operating cash flow: 210000000
Depreciation & amortization: 52000000
Net tangible assets: 8658000000
Owner earnings: 381000000
Return on net tangible assets (%): 4.4005544005544
Capex to operating income (%): 131.70731707317074
Buffett classification: The Gruesome
Stock price: 91.68
P/E ratio: 2.5707987391705074
Shares outstanding: 18254690
Book value: 10414000000
P/B ratio: 0.16070577868254274
Market cap (USD): 1673589979.2
Debt to equity: 0.3014211638179374
Current ratio: 0.6026490066225165
Quick ratio: 0.6026490066225165
Effective tax rate (%): 7.487922705314009
Interest coverage ratio: 1.025
COGS to revenue (%): 0
SG&A to revenue (%): 42.1455938697318
Free cash flow (dilution-adjusted): 83000000
Buyback yield (%): 0
Retained earnings: 7363000000
Receivables turnover: 1.962406015037594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.25642629307649006
FCF margin (%): 31.800766283524908
Rule of 40 score: 31.800766283524908
Financial ratios for LBRDA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -8000000
Net income: -154000000
Capital expenditures: 0
Operating cash flow: -265000000
Net tangible assets: 8870000000
Owner earnings: -154000000
Return on net tangible assets (%): -1.7361894024802704
Buffett classification: The Gruesome
Stock price: 63.33
P/E ratio: 2.3260956090543257
Shares outstanding: 18254690
Book value: 8870000000
P/B ratio: 0.1303347821533258
Market cap (USD): 1156069517.7
Debt to equity: 0.20202931228861332
Current ratio: 0.24285714285714285
Quick ratio: 0.24285714285714285
Effective tax rate (%): 0
Interest coverage ratio: -0.2857142857142857
Free cash flow (dilution-adjusted): -141000000
Buyback yield (%): 0
Retained earnings: 7209000000
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.06229074203846453
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for LBRDA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -5000000
Net income: -3173000000
Capital expenditures: 0
Operating cash flow: -231000000
Net tangible assets: 5698000000
Owner earnings: -3173000000
Return on net tangible assets (%): -55.68620568620568
Buffett classification: The Gruesome
Stock price: 48.28
Shares outstanding: 18254690
Book value: 5698000000
P/B ratio: 0.1546746987012987
Market cap (USD): 881336433.2
Debt to equity: 0.3064233064233064
Current ratio: 0.10435663627152988
Quick ratio: 0.10435663627152988
Interest coverage ratio: -0.20833333333333334
Free cash flow (dilution-adjusted): -232000000
Buyback yield (%): 0
Retained earnings: 4036000000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.06375111564452378
Rule of 40 score: 0
Financial ratios for LBRDA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -36000000
Net income: -2676000000
Capital expenditures: 0
Operating cash flow: -327000000
Net tangible assets: 5698000000
Owner earnings: -2676000000
Return on net tangible assets (%): -46.96384696384696
Buffett classification: The Gruesome
Stock price: 48.28
Shares outstanding: 18254690
Book value: 5698000000
P/B ratio: 0.1546746987012987
Market cap (USD): 881336433.2
Debt to equity: 0.3064233064233064
Current ratio: 0.10435663627152988
Quick ratio: 0.10435663627152988
Interest coverage ratio: -0.32727272727272727
Free cash flow (dilution-adjusted): -332000000
Buyback yield (%): 0
Retained earnings: 4036000000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4590080326405712
Rule of 40 score: 0
Financial ratios for MAXHEALTH.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.555716734801529
Shares outstanding: 973243789
Market cap (USD): 4433823016.588948
Buyback yield (%): 0
Retained earnings: 18749835.157589346
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAXHEALTH.NS — annual report dated 2023-03-31
Total revenue: 546766138.8550549
Gross profit: 434573690.6211937
Operating income: 127313032.88672352
Net income: 134410475.03045067
Capital expenditures: 40400730.816077955
Operating cash flow: 156410475.03045067
Depreciation & amortization: 28281364.190012183
Net tangible assets: 285516443.361754
Owner earnings: 122291108.40438491
Return on net tangible assets (%): 42.83154657031086
Capex to operating income (%): 31.7333818070491
Buffett classification: The Good
Stock price: 5.338855054811206
P/E ratio: 38.65775730120071
Shares outstanding: 973243789
Book value: 902507917.1741778
P/B ratio: 5.757298549507867
Market cap (USD): 5196007522.466261
Debt to equity: 0.12257763250058372
Current ratio: 1.8583834654781601
Quick ratio: 1.7854758648392741
Effective tax rate (%): -3.740646034670778
Interest coverage ratio: 14.655636567582725
COGS to revenue (%): 20.519275108878468
SG&A to revenue (%): 26.38679423918734
Free cash flow (dilution-adjusted): 111347137.63702802
Buyback yield (%): 0
Retained earnings: 150311814.85992694
Inventory turnover: 12.08316935589663
Receivables turnover: 13.355200523622514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.541604279019642
FCF margin (%): 20.36467325321066
Rule of 40 score: 20.36467325321066
Financial ratios for MAXHEALTH.NS — annual report dated 2024-03-31
Total revenue: 636704640.8442259
Gross profit: 502641803.57356995
Operating income: 154043650.3177839
Net income: 126830555.22244874
Capital expenditures: 93489627.05360354
Operating cash flow: 134508933.92493105
Depreciation & amortization: 29377623.216212977
Net tangible assets: 338831994.2439141
Owner earnings: 62718551.38505818
Return on net tangible assets (%): 18.510221127438495
Capex to operating income (%): 60.69034774282444
Buffett classification: The Good
Stock price: 9.789947216890596
P/E ratio: 75.12389508005695
Shares outstanding: 973243789
Book value: 1008291162.0098333
P/B ratio: 9.449656688931373
Market cap (USD): 9528005323.476608
Debt to equity: 0.1539650862140735
Current ratio: 1.3663540774078848
Quick ratio: 1.3024160934083973
Effective tax rate (%): 22.5353763220344
Interest coverage ratio: 28.82787253141831
COGS to revenue (%): 21.055734271529417
SG&A to revenue (%): 26.005748208864144
Free cash flow (dilution-adjusted): 34308670.10432905
Buyback yield (%): 0
Retained earnings: 262441539.75296798
Inventory turnover: 14.00237975951904
Receivables turnover: 11.475242603038751
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.94812128472742
FCF margin (%): 5.388474954232805
Revenue growth (%): 16.449171884986335
Rule of 40 score: 21.83764683921914
Financial ratios for MAXHEALTH.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 391118012.42236024
Buffett classification: The Gruesome
Stock price: 11.739966555183946
Shares outstanding: 973243789
Book value: 1051010511.2279024
P/B ratio: 10.8712990125585
Market cap (USD): 11425849532.900501
Debt to equity: 0.20095214716117407
Current ratio: 1.2629981508639927
Quick ratio: 1.2034304661098003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAXHEALTH.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.111668026576522
Shares outstanding: 973243789
Market cap (USD): 12760849470.295486
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAXHEALTH.NS — quarterly report dated 2025-03-31
Total revenue: 223256955.8101473
Gross profit: 175392798.69067103
Operating income: 48023147.065700255
Net income: 37292494.739303246
Capital expenditures: 0
Depreciation & amortization: 11787467.851297637
Net tangible assets: 391114098.66729015
Owner earnings: 49079962.590600885
Return on net tangible assets (%): 12.548758216039621
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.763916442992182
P/E ratio: 83.27682613014431
Shares outstanding: 973243789
Book value: 1096664718.260463
P/B ratio: 11.327438728184502
Market cap (USD): 12422402401.457113
Debt to equity: 0.3208966758946664
Current ratio: 0.8817387067662512
Quick ratio: 0.8229347182158933
Effective tax rate (%): 20.745341614906835
Interest coverage ratio: 7.440499909436697
COGS to revenue (%): 21.439044058353492
SG&A to revenue (%): 21.277241928220594
Buyback yield (%): 0
Retained earnings: 363684825.81248534
Inventory turnover: 3.8549100837962524
Receivables turnover: 2.7785715324962537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0636970654765587
Rule of 40 score: 0
Financial ratios for MAXHEALTH.NS — annual report dated 2025-03-31
Total revenue: 807851297.6385316
Gross profit: 635196399.3453355
Operating income: 184270516.7173252
Net income: 125775075.98784193
Capital expenditures: 109664484.45171848
Operating cash flow: 168103811.08253446
Depreciation & amortization: 42017769.46457797
Net tangible assets: 391114098.66729015
Owner earnings: 58128361.00070143
Return on net tangible assets (%): 14.862251501229979
Capex to operating income (%): 59.5127676447264
Buffett classification: The Good
Stock price: 12.763916442992182
P/E ratio: 98.76680498016893
Shares outstanding: 973243789
Book value: 1096664718.260463
P/B ratio: 11.327438728184502
Market cap (USD): 12422402401.457113
Debt to equity: 0.3208966758946664
Current ratio: 0.8817387067662512
Quick ratio: 0.8229347182158933
Effective tax rate (%): 23.49950581994781
Interest coverage ratio: 10.596638655462185
COGS to revenue (%): 21.372113753842058
SG&A to revenue (%): 26.36982733171644
Free cash flow (dilution-adjusted): 51308159.925181195
Buyback yield (%): 0
Retained earnings: 363684825.81248534
Inventory turnover: 13.90537614160625
Receivables turnover: 10.054211345680988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.75576936989076
FCF margin (%): 6.351188650084801
Revenue growth (%): 26.880070572028053
Rule of 40 score: 33.231259222112854
Financial ratios for MAXHEALTH.NS — quarterly report dated 2025-06-30
Total revenue: 237253685.93494034
Gross profit: 185154458.2260707
Operating income: 49001872.220922075
Net income: 36036742.3355956
Capital expenditures: 0
Depreciation & amortization: 12185817.92651533
Owner earnings: 48222560.26211093
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.887315703252984
P/E ratio: 197.58813975214295
Shares outstanding: 973243789
Market cap (USD): 14488987543.073133
Effective tax rate (%): 23.090178058587014
Interest coverage ratio: 7.63482224247949
COGS to revenue (%): 21.95929117120494
SG&A to revenue (%): 21.02960686930661
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 6.269336636792431
Rule of 40 score: 6.269336636792431
Financial ratios for MAXHEALTH.NS — quarterly report dated 2025-09-30
Total revenue: 240751972.9425028
Gross profit: 188340473.50620067
Operating income: 52655016.91093574
Net income: 55388951.52198421
Capital expenditures: 0
Depreciation & amortization: 12187147.688838782
Net tangible assets: 454198421.6459977
Owner earnings: 67576099.210823
Return on net tangible assets (%): 14.878100845425617
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.544757609921081
P/E ratio: 94.85145465030125
Shares outstanding: 973243789
Book value: 1133304396.843292
P/B ratio: 10.77301690734938
Market cap (USD): 12209107428.366177
Debt to equity: 0.3257945109680166
Current ratio: 0.7928226095824441
Quick ratio: 0.7388151309701422
Effective tax rate (%): -10.149541510660717
Interest coverage ratio: 8.661906528189911
COGS to revenue (%): 21.769914819688406
SG&A to revenue (%): 21.200485139102867
Buyback yield (%): 0
Inventory turnover: 4.064079027887053
Receivables turnover: 2.2765719281038783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2976910161308317
Revenue growth (%): 1.4744921638527286
Rule of 40 score: 1.4744921638527286
Financial ratios for MAXHEALTH.NS — quarterly report dated 2025-12-31
Total revenue: 230313022.16776207
Gross profit: 181259886.37629497
Operating income: 47573799.71037095
Net income: 33521220.897850063
Capital expenditures: 0
Depreciation & amortization: 12395009.468642086
Owner earnings: 45916230.36649215
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.621365712376072
P/E ratio: 69.71439328145946
Shares outstanding: 973243789
Market cap (USD): 11310421999.267572
Effective tax rate (%): 17.452131453338453
Interest coverage ratio: 7.157197921903805
COGS to revenue (%): 21.298463860083576
SG&A to revenue (%): 21.377785946447915
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.3359772495961195
Rule of 40 score: -4.3359772495961195
Financial ratios for MLHYD.PA — annual report dated 2021-09-30
Total revenue: 58333224.41860465
Operating income: 27791869.76744186
Net income: 23975746.51162791
Capital expenditures: 0
Net tangible assets: 63166823.255813956
Owner earnings: 23975746.51162791
Return on net tangible assets (%): 37.956232838448386
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 633.7209302325582
P/E ratio: 1.8437466990624538
Shares outstanding: 69755
Book value: 63186112.79069767
P/B ratio: 0.6996031491096891
Market cap (USD): 44205203.488372095
Debt to equity: 0.45872458322964216
Current ratio: 9.674871515690496
Quick ratio: 8.97575067073655
Effective tax rate (%): 13.759331823996712
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 4735687.209302326
Inventory turnover: 0
Receivables turnover: 28.598923576312522
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.31260480027665
Rule of 40 score: 0
Financial ratios for MLHYD.PA — annual report dated 2022-09-30
Total revenue: 44505816.666666664
Operating income: -3610660.7843137253
Net income: -3436513.725490196
Capital expenditures: 0
Net tangible assets: 52561775.49019608
Owner earnings: -3436513.725490196
Return on net tangible assets (%): -6.5380472661757425
Buffett classification: The Gruesome
Stock price: 519.6078431372549
Shares outstanding: 69755
Book value: 52572119.60784313
P/B ratio: 0.6894385345009346
Market cap (USD): 36245245.09803922
Debt to equity: 0.40632116158191806
Current ratio: 17.547280815038025
Quick ratio: 15.600518626549874
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 559261.7647058823
Inventory turnover: 0
Receivables turnover: 21.965579176313756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.890593624575072
Revenue growth (%): -23.704171833038444
Rule of 40 score: -23.704171833038444
Financial ratios for MTC — annual report dated 2021-12-31
Capital expenditures: 4752.307692307692
Buffett classification: The Gruesome
Stock price: 52.8
Shares outstanding: 99587811
Market cap (USD): 5258236420.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTC — annual report dated 2022-12-31
Total revenue: 137785.75096277278
Gross profit: 108121.56611039795
Operating income: -746035.6867779205
Net income: -724695.2503209242
Capital expenditures: 486.77792041078305
Operating cash flow: -717659.435173299
Depreciation & amortization: 8527.342747111681
Net tangible assets: 1204666.3671373555
Owner earnings: -716654.6854942233
Return on net tangible assets (%): -59.48988907171098
Buffett classification: The Gruesome
Stock price: 6.2
Shares outstanding: 99587811
Book value: 1204666.3671373557
P/B ratio: 512.5439250597084
Market cap (USD): 617444428.2
Debt to equity: 0.11226924483110232
Current ratio: 7.696595943686255
Quick ratio: 7.696595943686255
COGS to revenue (%): 21.529210854603946
SG&A to revenue (%): 619.9169703107372
Free cash flow (dilution-adjusted): -718146.2130937099
Buyback yield (%): 0
Retained earnings: -2856614.8908857508
Receivables turnover: 0.21798253176315383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.74530424200006
FCF margin (%): -521.2049925886313
Rule of 40 score: -521.2049925886313
Financial ratios for MTC — annual report dated 2023-12-31
Total revenue: 111387.32394366198
Gross profit: 89242.89372599233
Operating income: -549338.9244558259
Net income: 5826079.769526249
Capital expenditures: 870.8066581306018
Operating cash flow: -659604.0973111396
Depreciation & amortization: 5861.971830985915
Net tangible assets: 15225096.798975673
Owner earnings: 5831070.934699104
Return on net tangible assets (%): 38.29907298252063
Buffett classification: The Gruesome
Stock price: 8
P/E ratio: 136.74761066046722
Shares outstanding: 99587811
Book value: 15225096.798975673
P/B ratio: 52.3282379428682
Market cap (USD): 796702488
Debt to equity: 0.27887757196096624
Current ratio: 0.5547420091340958
Quick ratio: 0.5547420091340958
Interest coverage ratio: -1.0208258284338336
COGS to revenue (%): 19.88056578939806
SG&A to revenue (%): 636.5215791984458
Free cash flow (dilution-adjusted): -659728.2970550576
Buyback yield (%): 0
Retained earnings: 2976780.153649168
Receivables turnover: 0.8495749366433423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8312165503851765
FCF margin (%): -592.2831016110399
Revenue growth (%): -19.159039911349893
Rule of 40 score: -611.4421415223898
Financial ratios for MTC — annual report dated 2024-12-31
Total revenue: 240764.56185567012
Gross profit: 196552.8350515464
Operating income: -12001530.154639175
Net income: -11748489.69072165
Capital expenditures: 648.9690721649484
Operating cash flow: 93151.15979381444
Depreciation & amortization: 6025.644329896907
Net tangible assets: 3428242.912371134
Owner earnings: -11743113.015463918
Return on net tangible assets (%): -342.54028421054414
Buffett classification: The Gruesome
Stock price: 1.57
Shares outstanding: 99587811
Book value: 3428242.9123711353
P/B ratio: 45.60728841756985
Market cap (USD): 156352863.27
Debt to equity: 1.2166279087469476
Current ratio: 0.4126038904518863
Quick ratio: 0.4126038904518863
Interest coverage ratio: -38.44783122761418
COGS to revenue (%): 18.36305412364926
SG&A to revenue (%): 236.62173713144284
Free cash flow (dilution-adjusted): 92502.19072164949
Buyback yield (%): 0
Retained earnings: -8752529.25257732
Receivables turnover: 376.6041120741786
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -158.96564316848523
FCF margin (%): 38.42018526675919
Revenue growth (%): 116.15077311440321
Rule of 40 score: 154.5709583811624
Financial ratios for MTC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3428242.912371134
Buffett classification: The Gruesome
Stock price: 1.57
Shares outstanding: 99587811
Book value: 3428242.9123711353
P/B ratio: 45.60728841756985
Market cap (USD): 156352863.27
Debt to equity: 1.2166279087469476
Current ratio: 0.4126038904518863
Quick ratio: 0.4126038904518863
Buyback yield (%): 0
Retained earnings: -8752529.25257732
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -2525135.796178344
Buffett classification: The Gruesome
Stock price: 1.04
Shares outstanding: 99587811
Book value: -2525135.796178344
Market cap (USD): 103571323.44
Debt to equity: -1.6357514429696307
Current ratio: 1.316057992296807
Quick ratio: 1.316057992296807
Buyback yield (%): 0
Retained earnings: -14566654.649681529
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTM.AX — annual report dated 2022-06-30
Operating income: -879979.3103448276
Net income: -882285.5172413794
Capital expenditures: 28880.689655172413
Depreciation & amortization: 10382.068965517241
Net tangible assets: 3448110.3448275863
Owner earnings: -900784.1379310346
Return on net tangible assets (%): -26.123993951709686
Buffett classification: The Gruesome
Stock price: 0.08275862068965517
Shares outstanding: 736842626
Book value: 3462992.413793104
P/B ratio: 17.609071030655365
Market cap (USD): 60980079.39310345
Debt to equity: 0.00431797176012215
Current ratio: 3.353478196673924
Quick ratio: 3.353478196673924
Interest coverage ratio: -381.569976076555
Free cash flow (dilution-adjusted): -2106681.379310345
Buyback yield (%): 0.37321402195860476
Retained earnings: -1489837.9310344828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.362310918632176
Rule of 40 score: 0
Financial ratios for MTM.AX — annual report dated 2023-06-30
Operating income: -1167172.847682119
Net income: -1158464.238410596
Capital expenditures: 3729.801324503311
Depreciation & amortization: 12492.05298013245
Net tangible assets: 5620914.569536424
Owner earnings: -1149701.986754967
Return on net tangible assets (%): -20.45400214737273
Buffett classification: The Gruesome
Stock price: 0.06622516556291391
Shares outstanding: 736842626
Book value: 5642547.01986755
P/B ratio: 8.648137929350867
Market cap (USD): 48797524.90066226
Debt to equity: 0.0016119252894810782
Current ratio: 6.918811975591152
Quick ratio: 6.918811975591152
Interest coverage ratio: -573.5213146762121
Free cash flow (dilution-adjusted): -2250195.3642384107
Buyback yield (%): 0.5195763470936872
Retained earnings: -2589103.3112582783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.67882711436525
Rule of 40 score: 0
Financial ratios for NXP — annual report dated 2022-03-31
Total revenue: -43691774
Net income: -44130556
Capital expenditures: 0
Net tangible assets: 708249156
Owner earnings: -44130556
Return on net tangible assets (%): -6.230936616887405
Buffett classification: The Gruesome
Stock price: 12.06
Shares outstanding: 63015710
Book value: 708249156
P/B ratio: 1.0730255816923275
Market cap (USD): 759969462.6
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 52737696
Receivables turnover: -4.908206999971578
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXP — annual report dated 2023-03-31
Total revenue: 77198
Net income: -299200
Capital expenditures: 0
Net tangible assets: 682055821
Owner earnings: -299200
Return on net tangible assets (%): -0.04386737724213338
Buffett classification: The Gruesome
Stock price: 12.45
Shares outstanding: 63015710
Book value: 682055821
P/B ratio: 1.1502659538184632
Market cap (USD): 784545589.5
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 453.7267804865411
Buyback yield (%): 0
Retained earnings: 26464719
Receivables turnover: 0.011579845327058854
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXP — annual report dated 2024-03-31
Total revenue: 31687650
Net income: 31398805
Capital expenditures: 0
Net tangible assets: 702328149
Owner earnings: 31398805
Return on net tangible assets (%): 4.4706744339817135
Buffett classification: The Gruesome
Stock price: 13.09
P/E ratio: 26.27092476608584
Shares outstanding: 63015710
Book value: 702328149
P/B ratio: 1.17448751708797
Market cap (USD): 824875643.9
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.8514642139761074
Buyback yield (%): 0
Retained earnings: 30352935
Receivables turnover: 2.2946019631199923
Capitalized R&D asset: 0
Revenue growth (%): 40947.24215653256
Rule of 40 score: 40947.24215653256
Financial ratios for NXP — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 726015189
Buffett classification: The Gruesome
Stock price: 13.98
Shares outstanding: 63015710
Book value: 726015189
P/B ratio: 1.2134176242420185
Market cap (USD): 880959625.8000001
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 35689886
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXP — annual report dated 2025-03-31
Total revenue: 9880662
Net income: 9543995
Capital expenditures: 0
Net tangible assets: 724302242
Owner earnings: 9543995
Return on net tangible assets (%): 1.3176812726198905
Buffett classification: The Gruesome
Stock price: 13.58
P/E ratio: 89.66406015510276
Shares outstanding: 63015710
Book value: 724302242
P/B ratio: 1.1814865289344223
Market cap (USD): 855753341.8
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 3.2254923809760925
Buyback yield (%): 0
Retained earnings: 9565464
Receivables turnover: 0.6971667995287243
Capitalized R&D asset: 0
Revenue growth (%): -68.81857127303539
Rule of 40 score: -68.81857127303539
Financial ratios for NXP — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 724302242
Buffett classification: The Gruesome
Stock price: 13.58
Shares outstanding: 63015710
Book value: 724302242
P/B ratio: 1.1814865289344223
Market cap (USD): 855753341.8
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 9565464
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXP — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 743356971
Buffett classification: The Gruesome
Stock price: 13.98
Shares outstanding: 63015710
Book value: 743356971
P/B ratio: 1.1851097926947403
Market cap (USD): 880959625.8000001
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 12311441
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PANW — annual report dated 2021-07-31
Capital expenditures: 0
Depreciation & amortization: 304900000
Buffett classification: The Gruesome
Stock price: 66.51
Shares outstanding: 815000000
Market cap (USD): 54205650000.00001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PANW — annual report dated 2022-07-31
Total revenue: 5501500000
Gross profit: 3782800000
Operating income: -188800000
Net income: -267000000
Capital expenditures: 192800000
Operating cash flow: 1984700000
Depreciation & amortization: 282600000
Net tangible assets: -2922200000
Owner earnings: -177200000
Buffett classification: The Gruesome
Stock price: 83.18
Shares outstanding: 815000000
Book value: 210000000
P/B ratio: 322.8176190476191
Market cap (USD): 67791700000.00001
Debt to equity: 18.823333333333334
Current ratio: 0.7722933195285506
Quick ratio: 0.7722933195285506
Interest coverage ratio: -9.346534653465346
COGS to revenue (%): 31.240570753430884
R&D to revenue (%): 25.769335635735708
SG&A to revenue (%): 46.42188494047078
Free cash flow (dilution-adjusted): 780800000
Buyback yield (%): 1.3162378285247307
Retained earnings: -1667100000
Receivables turnover: 2.4409885526666075
Capitalized R&D asset: 1417700000
ROCI (R&D-adjusted, %): 14.097545821683752
FCF margin (%): 14.192492956466419
Rule of 40 score: 14.192492956466419
Financial ratios for PANW — annual report dated 2023-07-31
Total revenue: 6892700000
Gross profit: 4983000000
Operating income: 387300000
Net income: 439700000
Capital expenditures: 146300000
Operating cash flow: 2777500000
Depreciation & amortization: 282200000
Net tangible assets: -1493800000
Owner earnings: 575600000
Return on net tangible assets (%): -38.53260141919936
Capex to operating income (%): 37.77433514071779
Buffett classification: The Good
Stock price: 124.98
P/E ratio: 231.6549920400273
Shares outstanding: 815000000
Book value: 1748400000
P/B ratio: 58.258236101578596
Market cap (USD): 101858700000
Debt to equity: 1.2987302676733012
Current ratio: 0.7816478190630048
Quick ratio: 0.7816478190630048
Effective tax rate (%): 22.355641885926186
Interest coverage ratio: 18.89268292682927
COGS to revenue (%): 27.7061238701815
R&D to revenue (%): 23.2709968517417
SG&A to revenue (%): 43.40389107316437
Free cash flow (dilution-adjusted): 1556700000
Buyback yield (%): 0.267723817405877
Retained earnings: -1227400000
Receivables turnover: 2.41679523141655
Capitalized R&D asset: 2553859000
ROCI (R&D-adjusted, %): 10.56153471313012
Rosenberg metric: 0.8465824927699795
FCF margin (%): 22.584763590465275
Revenue growth (%): 25.287648823048258
Rule of 40 score: 47.87241241351353
Financial ratios for PANW — annual report dated 2024-07-31
Total revenue: 8027500000
Gross profit: 5968300000
Operating income: 683900000
Net income: 2577600000
Capital expenditures: 156800000
Operating cash flow: 3257600000
Depreciation & amortization: 283300000
Net tangible assets: 1444700000
Owner earnings: 2704100000
Return on net tangible assets (%): 187.17380771094346
Capex to operating income (%): 22.92732855680655
Buffett classification: The Great
Stock price: 162.37
P/E ratio: 51.33905571073867
Shares outstanding: 815000000
Book value: 5169700000
P/B ratio: 25.597529837321314
Market cap (USD): 132331550000
Debt to equity: 0.260053774880554
Current ratio: 0.8915745766462312
Quick ratio: 0.8915745766462312
Effective tax rate (%): -160.81149448548013
Interest coverage ratio: 142.47916666666666
COGS to revenue (%): 25.65182186234818
R&D to revenue (%): 22.540018685767674
SG&A to revenue (%): 43.288695110557455
Free cash flow (dilution-adjusted): 2025400000
Buyback yield (%): 0.4282425468454046
Retained earnings: 1350200000
Receivables turnover: 2.400209298848856
Capitalized R&D asset: 3351921000
ROCI (R&D-adjusted, %): 5.638100327151579
Rosenberg metric: 0.6142768079800499
FCF margin (%): 25.23076923076923
Revenue growth (%): 16.46379502952399
Rule of 40 score: 41.69456426029322
Financial ratios for PANW — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 180.16
Shares outstanding: 815000000
Market cap (USD): 146830400000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PANW — quarterly report dated 2025-01-31
Total revenue: 2257000000
Gross profit: 1658000000
Operating income: 241000000
Net income: 267000000
Capital expenditures: 48000000
Operating cash flow: 557000000
Depreciation & amortization: 87000000
Net tangible assets: 1553100000
Owner earnings: 306000000
Return on net tangible assets (%): 19.702530423024918
Capex to operating income (%): 19.91701244813278
Buffett classification: The Great
Stock price: 184.42
P/E ratio: 140.7324906367041
Shares outstanding: 815000000
Book value: 6375300000
P/B ratio: 23.575721926811283
Market cap (USD): 150302300000
Debt to equity: 0.14066789013850328
Current ratio: 0.8394639972458356
Quick ratio: 0.8394639972458356
Effective tax rate (%): 17.846153846153847
Interest coverage ratio: 241
COGS to revenue (%): 26.53965440850687
R&D to revenue (%): 22.374833850243686
SG&A to revenue (%): 40.40762073548959
Free cash flow (dilution-adjusted): 189000000
Buyback yield (%): 0
Retained earnings: 1968200000
Receivables turnover: 1.002932811944543
Capitalized R&D asset: 505000000
ROCI (R&D-adjusted, %): 4.154530307933882
FCF margin (%): 8.373947718210013
Rule of 40 score: 8.373947718210013